Kasinrerk
Watchara Kasinrerk, Chiangmai TH
Patent application number | Description | Published |
---|---|---|
20090004721 | Dengue virus mutant strain MBU 01-2002 - The invention includes a genetic construct and a mutant dengue virus, designated as strain MBU 01-2002, which is a mutant dengue virus generated by genetic modification of the 13-amino acid sequence just proximal to the pr-M junction within the prM coding region of the genome. The modification involves increasing the number of positively charged amino acid and abolishing the negatively charged amino acid in this pr-M junction sequence. The mutant dengue virus strain MBU 01-2002 possesses less prM protein on the viral envelope than the prototype dengue virus, is capable of inducing infected C6/36 cells to fuse at neutral pH, is as efficient as the prototype virus in the intracellular multiplication, but is defective in its release from infected cells. | 01-01-2009 |
Watchara Kasinrerk, Nonpung TH
Patent application number | Description | Published |
---|---|---|
20080233659 | PROCESS OF SCREENING FOR ALPHA-THALASSEMIA CARRIER USING IMMUNOCHROMATOGRAPHIC STRIP TEST - The invention provides a device and method for the rapid identification of patients suspected of having thalassemia. The invention provides a test strip for the aqueous detection of thalassemia related proteins in whole blood. The test strip includes antibodies specific to the gamma 4, (γ4) protein and provides easy visual discrimination between a positive result and a negative result. The invention can be used in remote or clinical settings. | 09-25-2008 |
Watchara Kasinrerk, Chiang Mai TH
Patent application number | Description | Published |
---|---|---|
20150313954 | METHOD OF ADMINISTRATING A SERIES OF COMPOSITIONS FOR DYNAMIC IMMUNE MODULATION - The present disclosure provides a series of compositions, or a single composition formulation (e.g., which includes distinct time release portions), supportive of or resulting in antipode immune system effects. A method of administrating the series of compositions or the single composition formulation to support, provide, enhance, or improve health benefit by way of modulating aspects immune system function is also provided. | 11-05-2015 |